Vaccination against Covid-19: why Novavax, examined in the United States, “flopped” in France

Will he find more of his place in the United States than in France? The vaccine against Covid-19 developed by the company Novavax, administered in France since the beginning of March, could very soon be authorized across the Atlantic. Tuesday evening, a group of experts convened at the request of the Food and Drug Administration (DGA) considered that the expected benefits of this vaccine outweighed the possible risks. We are now awaiting the final decision of the FDA, which generally follows the recommendations of this committee.